
Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery
The Long Run with Luke Timmerman
AI in Therapeutic Innovation and Drug Discovery
The chapter explores the impact of AI in drug discovery, emphasizing its role in automating tasks, enabling expert decision-making, and driving hypothesis-free research with omics data. It discusses the advantages small startups have in quickly curating purpose-built data sets for AI compared to larger pharmaceutical companies. The conversation also touches on the importance of learning from negative data, the hype surrounding AI in healthcare, and the potential of AI to speed up the drug discovery process.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.